Property | Value |
?:abstract
|
-
INTRODUCTION Patients with substance use disorder may be particularly vulnerable to withdrawal-related complications during the SARS-CoV-2 (COVID-19) pandemic. Limited availability of alcohol and other substances coupled with decreased accessibility to substance use treatment poses a substantial risk to this population. Isopropanol, the active ingredient in rubbing alcohol, is widely available; thus, it may be used in times of scarcity. CASE REPORT We present a case of intentional isopropanol ingestion used as an ethanol surrogate within the setting of the COVID-19 pandemic. CONCLUSIONS Toxic alcohol ingestions are imperative considerations on the differential for the intoxicated patient particularly during resource-limited times.
|
?:creator
|
|
?:doi
|
-
10.1097/adm.0000000000000728
|
?:doi
|
|
?:journal
|
-
Journal_of_addiction_medicine
|
?:license
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:source
|
|
?:title
|
-
A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic.
|
?:type
|
|
?:year
|
|